发明名称 <i>IN VITRO</i> ACTIVATED GAMMA DELTA LYMPHOCYTES
摘要 Patients who develop increased numbers of gamma delta + cytotoxic T lymphocytes 2-6 months after allogeneic bone marrow transplantation are less likely to relapse than those who do not. The gamma delta + T cells isolated from blood of patients with increased gamma delta + T cells are CD3+CD4-CD8-CD57+, cytolytic to K562 cells, and express the V delta 1 T cell receptor phenotype. Similar gamma delta + T cells can be generated in vitro by culture of donor mononuclear cells which are enriched for gamma delta + T cells by immunomagnetic depletion of depleted of CD4+ and CD8+ cells. This gamma delta -enriched cell preparation was cultured on a combination of immobilized pan- delta monoclonal antibody and irradiated recipient B cell leukemia. After four weeks, the cultures were almost exclusively V delta 1+CD3+CD4-CD8- cells that co-expressed activation-associated antigens CD69, CD25, and HLA-DR. Furthermore, they were cytolytic against the primary leukemia obtained from the recipient and lymphoblastic leukemia cell lines, yet had minimal cytotoxicity against normal donor-derived mononuclear cells or myeloid leukemia cell lines. These observations suggest that donor-derived cytotoxic gamma delta + T cells can be generated in vitro, and may provide therapeutic potential for prevention of disease relapse.
申请公布号 WO0044893(A9) 申请公布日期 2001.10.18
申请号 WO2000US01867 申请日期 2000.01.27
申请人 PALMETTO HEALTH ALLIANCE D/B/A PALMETTO RICHLAND MEMORIAL HOSPITAL;LAMB, LAWRENCE, S., JR. 发明人 LAMB, LAWRENCE, S., JR.
分类号 C12N5/02;A61K35/14;A61P35/02;C12N5/0783;C12N15/07;(IPC1-7):C12N15/07;C12N15/01;C12N5/06 主分类号 C12N5/02
代理机构 代理人
主权项
地址